AKTS
Aktis Oncology, Inc.
19.60$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 120.4% | 115.5% | 90.3% | 95.4% | 52.3% | – | – | – | – | – | 20.2% | 26.0% | – | |
| -20.4% | -15.5% | 9.7% | 4.6% | 47.7% | 100.0% | – | – | 100.0% | 100.0% | 79.8% | 74.0% | 84.8% | |
| 98.0% | 147.8% | 91.4% | 79.5% | 29.8% | 1,351.1% | 1,096.3% | 1,163.5% | 1,042.9% | 882.0% | 620.9% | 747.0% | 778.1% | |
| 96.7% | 146.0% | 132.4% | 119.0% | 76.9% | 422.4% | 231.2% | 229.9% | 193.9% | 134.2% | 165.5% | 189.2% | 172.1% | |
| 194.7% | 293.8% | 223.8% | 210.3% | 106.8% | 1,775.8% | 1,353.8% | 1,409.4% | 1,252.8% | 1,029.1% | 783.4% | 928.0% | 951.4% | |
| -215.2% | -309.3% | -214.1% | -301.0% | -59.1% | -1,675.8% | -1,253.8% | -1,309.4% | -1,152.8% | -929.1% | -703.6% | -854.0% | -866.6% | |
| 4.4% | 6.9% | 9.7% | 9.9% | 7.9% | – | – | – | – | – | – | – | – | |
| -213.5% | -287.5% | -223.9% | -310.3% | -71.1% | -1,292.2% | -1,035.6% | -1,129.0% | -983.7% | -809.5% | -567.9% | -713.5% | -727.0% | |
| -0.3% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| -213.2% | -287.5% | -223.9% | -310.4% | -71.1% | -1,292.2% | -1,035.6% | -1,129.0% | -983.7% | -809.5% | -567.9% | -713.5% | -727.0% | |
| -171.0% | -264.6% | -166.8% | -255.5% | -44.5% | -1,244.9% | – | – | -1,114.9% | -772.4% | -547.7% | -828.0% | -772.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.